Ausgabe Sonderheft 5/2007
Severe sepsis and drotrecogin alfa (activated)
Inhalt (7 Artikel)
Review
Recombinant human activated protein C: current insights into its mechanism of action
Marcel Levi, Tom van der Poll
Review
The protein C pathway: implications for the design of the RESPOND study
Burkhard Vangerow, Andrew F Shorr, Duncan Wyncoll, Jonathan Janes, David R Nelson, Konrad Reinhart
Review
Practical aspects of treatment with drotrecogin alfa (activated)
Luigi Camporota, Duncan Wyncoll
Introduction
Introduction: severe sepsis and drotrecogin alfa (activated)
Antonio Artigas, Claude D Martin